Variation of prothrombotic state markers in patients with type 2 diabetes mellitus who have microvascular complication
10.3760/cma.j.issn.1673-4904.2015.11.016
- VernacularTitle:2型糖尿病合并微血管病变对凝血及抗凝功能的影响
- Author:
Bo CHEN
;
Zhiqi CHEN
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Microvascular complication;
Blood coagulation;
Anti-coagulation
- From:
Chinese Journal of Postgraduates of Medicine
2015;(11):834-836
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the variation of coagulation parameters in type 2 diabetes mellitus(T2DM)patients with microvascular complication. Methods Coagulation and fibrinolysis parameters were measured in 40 healthy controls (control group) and 80 T2DM patients (T2DM group) with (47 patients) and without (33 patients) microvasular complications. Results Compared with those in control group, the serum levels of fibrinogenand D-D dimmersin in T2DM group were found to be increased significantly:(4.29±1.70) mg/L vs. (3.12±0.49) mg/L, 0.395 (0.265-0.910) mg/L vs. 0.215 (0.163-0.300) mg/L, P<0.05;while the activity of antithrombin III and protein S levels were significantly decreased in T2DM group:(94.11±25.04)%vs. (103.90±12.48)%,(70.23±23.22)%vs. (90.35±17.35)%, P<0.05. Amongst the T2DM patients, the serum levels of APTT, fibrinogen,D-D dimmers, and the activity of protein S in patients with microvascular complication were found to be significantly higher than those in patients without microvascular complication:(38.09±5.73) s vs. (34.53±4.13) s,(4.60±1.93) mg/L vs.(3.86±1.21) mg/L, 0.630(0.320-1.200) mg/L vs 0.310(0.240-0.405) mg/L, (79.4± 22.16)%vs. (57.15±18.05)%, P<0.05. Conclusion Hypercoagulable state and decreased anti-coagulation ability may contribute to the risk of development of microvascular complication in T2DM patients.
